Author

J.-Y. Low

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Bhamidipati· 1 shared A. Delcourt· 1 shared A. Jones· 1 shared A. M. De Marzo· 1 shared A. M. Vaghasia· 1 shared A. Petcherski· 1 shared A. S. Divakaruni· 1 shared A. S. Goldstein· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bhamidipati

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Androgen receptor inhibition induces metabolic reprogramming and increased reliance on oxidative mitochondrial metabolism in prostate cancer

P. Crowell, J. Giafaglione, A. Jones, N. Nunley, T. Hashimoto, A. Delcourt, A. Petcherski, M. Bernard, R. R. Huang, J.-Y. Low, N. Matulionis, X. Guan, N. Navone, J. Alumkal, M. Haffner, , A. S. Goldstein

This study shows that androgen receptor inhibition in prostate cancer cells shifts metabolism to oxidative mitochondrial pathways and increases sensitivity to complex I inhibitors.

Cell Reports · Oct 1, 2023Peer-reviewedCancer Biology

PHENOTYPIC CHARACTERIZATION OF TWO NOVEL CELL LINE MODELS OF CASTRATION RESISTANT PROSTATE CANCER.

M. C. Haffner, A. Bhamidipati, H. K. Tsai, D. M. Esopi, A. M. Vaghasia, J.-Y. Low, R. A. Patel, G. Guner, M.-T. Pham, N. Castagna, J. Hicks, N. Wyhs, R. Aebersold, A. M. De Marzo, W. G. Nelson, , S. Yegnasubramanian

This study develops two novel castration-resistant prostate cancer cell lines and characterizes their transcriptomic and proteomic profiles to understand resistance mechanisms.

bioRxiv · Jul 4, 2021 · PreprintCancer Biology